As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At PTC Therapeutics, a filing with the SEC revealed that on Tuesday, Director Dawn Svoronos purchased 25,000 shares of PTCT, for a cost of $13.49 each, for a total investment of $337,230. Investors are able to pick up PTCT even cheaper than Svoronos did, with shares changing hands as low as $12.52 in trading on Thursday -- that's 7.2% below Svoronos's purchase price. PTC Therapeutics is trading up about 1.1% on the day Thursday. This purchase marks the first one filed by Svoronos in the past year.
And at G1 Therapeutics, there was insider buying on Monday, by Director Glenn P. Muir who bought 20,000 shares for a cost of $15.00 each, for a trade totaling $300,000. G1 Therapeutics is trading up about 0.8% on the day Thursday. So far Muir is in the green, up about 13.3% on their purchase based on today's trading high of $17.00.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.